拜瑞妥医保后多少钱？

(Rivaroxaban) is produced by Bayer Healthcare Co., Ltd. Its main clinical indications are: 1. Used in adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis (VTE). 2. Used to treat venous thrombosis (DVT) in adults and reduce the risk of DVT recurrence and pulmonary embolism (PE) after acute DVT. 3. For use in adult patients with nonvalvular atrial fibrillation who have one or more risk factors (e.g., congestive heart failure, hypertension, age ≥75 years, diabetes, history of stroke or transient ischemic attack) to reduce the risk of stroke and systemic embolism. Today let’s take a closer look at how much it will cost after Xarelto health insurance?

Xarelto (rivaroxaban) was approved by the State Food and Drug Administration for marketing in China in 2009. In the same year, Xarelto was also included in the national medical insurance catalog, which relieved a certain burden on the treatment of many domestic patients.

Although the price of Xarelto tablets after medical insurance has been reduced, it is still unaffordable for some domestic patients who have been taking the medicine for a long time and whose families have limited financial conditions, so patients have turned their attention overseas. 

According to Medical Companion Travel, Xarelto 10mgx28 tablets is about 170, 15mgx28 tablets is about 500$, and 20mgx28 tablets is about 500$. Since exchange rates fluctuate and prices are not fixed, please consult Medical Travel for specific prices. Patients in need can purchase Xarelto (rivaroxaban) at major domestic pharmacies or obtain Xarelto (rivaroxaban) through domestic professional overseas medical service institutions (such as Medical Travel) to ensure that the drug is genuine.

Xarelto (rivaroxaban) has different indications and drug specifications. Therefore, when patients are actually treated with Xarelto, they must strictly follow the doctor's instructions or use the medication according to the instructions. Otherwise, the efficacy of the drug may be reduced, and it may even lead to the occurrence of some unsafe incidents, endangering the patient's own health and life safety.

Xarelto (rivaroxaban) is a highly selective oral drug that directly inhibits factor Xa. By inhibiting factor Xa, it can interrupt the intrinsic and extrinsic pathways of the coagulation cascade and inhibit thrombin generation and thrombosis.

The above is the content of (rivaroxaban) medical insurance, I hope it can help you!

Recommended related hot articles: /newsDetail/76546.html